Suppr超能文献

一种反应性可调自毁设计使组蛋白去乙酰化酶靶向成像和前药激活成为可能。

A Reactivity-Tunable Self-Immolative Design Enables Histone Deacetylase-Targeted Imaging and Prodrug Activation.

机构信息

State Key Laboratory of Chemo/Bio-Sensing and Chemometrics, College of Chemistry and Chemical Engineering, Hunan University, Changsha, 410082, P. R. China.

出版信息

Angew Chem Int Ed Engl. 2022 Nov 21;61(47):e202203243. doi: 10.1002/anie.202203243. Epub 2022 Oct 25.

Abstract

Histone deacetylase (HDAC)-targeted probes and prodrugs are crucial for cancer theranostics. We developed a self-immolative design that enables in vivo activatable near-infrared fluorescence (NIRF) and photoacoustic (PA) imaging and prodrug release in response to HDAC. This design comprises a phenyl ester linker with tunable reactivity, facilitating efficient release of caged fluorophores/drugs upon deacetylation. We engineered a new fluorophore using a spirocyclic xanthene scaffold with ring-open property, affording NIRF/PA detection with high contrast. We showed that a nitro-substituted self-immolative linker allows sensitive NIRF/PA in vivo imaging of HDAC with minimal interference. A highly efficient prodrug system was further developed for targeted therapy in HDAC-overexpressed triple negative breast tumors in mice. Our study provides a valuable paradigm for HDAC-targeted NIRF/PA imaging and prodrug release in vivo, highlighting its potential for bioimaging and drug development.

摘要

组蛋白去乙酰化酶 (HDAC) 靶向探针和前药对于癌症治疗学至关重要。我们开发了一种自毁型设计,能够在体内激活近红外荧光 (NIRF) 和光声 (PA) 成像,并响应 HDAC 释放前药。该设计包含一个具有可调反应性的苯酯连接体,可促进在去乙酰化后有效释放被封闭的荧光团/药物。我们使用具有开环性质的螺环吖啶骨架设计了一种新型荧光团,提供了具有高对比度的 NIRF/PA 检测。我们表明,硝基取代的自毁型连接体允许使用最小干扰的灵敏 NIRF/PA 进行体内 HDAC 成像。还进一步开发了高效的前药系统,用于在荷有 HDAC 过表达的三阴性乳腺癌小鼠中进行靶向治疗。我们的研究为体内 HDAC 靶向 NIRF/PA 成像和前药释放提供了一个有价值的范例,突出了其在生物成像和药物开发方面的潜力。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验